22 unknown. 22 Phase 2, 3 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 22 | Unknown 22 |
| Phase 1 | 3 | Unknown 3 |
| Phase 3 | 3 | Unknown 3 |
Follow Vasculitis: new trials by email Literature Review of Vasculitis trials Research Report on Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers Topical Pentoxifylline Gel (Vehicle +PTX), Topical Placebo Gel (Vehicle) - Behcet Syndrome, Behcet Disease | Phase 2 | Unknown | Silk Road Therapies, Inc. | 60 | 2024-02-01 | 2023-08-03 |
| Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis Methotrexate, Sodium chloride - Giant Cell Arteritis | Phase 2 | Unknown | University of Bonn | 52 | 2022-11-23 | 2024-04-10 |
| COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases COVID-19 vaccine - Rheumatoid Arthritis, Autoimmune Rheumatologic Disease | Phase 2 / Phase 3 | Unknown | Paul R Fortin | 287 | 2022-03-09 | 2023-01-17 |
| Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis) Belimumab, Placebo - Vasculitis, Cryoglobulinemia | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 48 | 2021-10-20 | 2024-06-26 |
| Defibrotide in Children With High Risk Kawasaki Disease Defibrotide - Kawasaki Disease | Phase 2 | Unknown | New York Medical College | 2 | 2021-02-24 | 2023-10-26 |
| Ointment Therapy and Prevention of Cannulation-Induced Superficial Phlebitis Nitroglycerin ointment, Clobetasol Topical - Phlebitis | Phase 1 / Phase 2 | Unknown | Komar University of Science and Technology | 110 | 2021-02-01 | 2020-12-28 |
| Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA tocilizumab and IV steroids combination, IV steroids combination alone - Giant Cell Arteritis, Optic Ischaemic Neuropathy | Phase 2 | Unknown | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 58 | 2020-09-10 | 2022-03-18 |
| Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis Infliximab, Tocilizumab - Takayasu Arteritis | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 50 | 2020-09-01 | 2020-09-25 |
| Inflammation Reduction by TREhalose AdminisTration Trehalose, Normal saline - Acute Coronary Syndrome | Phase 2 | Unknown | Mashhad University of Medical Sciences | 15 | 2020-08-20 | 2020-09-21 |
| Rituximab and Belimumab Combination Therapy in PR3 Vasculitis Belimumab, Rituximab, Prednisolone - ANCA Associated Vasculitis, Granulomatosis With Polyangiitis | Phase 2 | Unknown | Rachel Jones | 31 | 2019-02-01 | 2022-03-08 |
| Anti IL-18 (GSK1070806) in Behcet's Disease GSK1070806 - Behcet's Disease | Phase 2 | Unknown | Cambridge University Hospitals NHS Foundation Trust | 12 | 2018-08-01 | 2018-05-11 |
| Anti-inflammatory Treatment for Inactive Takayasu Arteritis Prednisone, cyclophosphamide - Takayasu Arteritis, Anti-Inflammatory Agents | Phase 2 / Phase 3 | Unknown | Chinese Academy of Medical Sciences, Fuwai Hospital | 40 | 2018-06-01 | 2018-06-08 |
| Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia ADRC injection, ADRC isolation, Liposuction - Critical Limb Ischemia, Arteriosclerosis Obliterans | Phase 1 / Phase 2 | Unknown | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 9 | 2016-07-01 | 2016-08-12 |
| The Research of Standard Diagnosis and Treatment for Severe HSP in Children Dexamethasone, Gamma globulin, Hemoperfusion - Henoch-Schoenlein Purpura | Phase 2 | Unknown | Nanjing Children's Hospital | 30 | 2015-08-01 | 2020-02-26 |
| Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis remicade (anti tumor necrosis factor inhibitor) - Takayasu's Arteritis | Phase 2 | Unknown | Seoul National University Hospital | 11 | 2015-03-01 | 2017-05-15 |
| CMV Modulation of the Immune System in ANCA-associated Vasculitis Valaciclovir - ANCA Associated Vasculitis, CMV Infection | Phase 2 | Unknown | Professor Lorraine Harper | 38 | 2013-07-01 | 2016-11-30 |
| Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia ResQ processed bone marrow sample, Ficoll conventional cell processing method - Critical Limb Ischemia, Peripheral Arterial Disease | Phase 1 / Phase 2 | Unknown | Xuanwu Hospital, Beijing | 50 | 2011-10-01 | 2011-10-12 |
| Research on the Blood- Cooling - Toxin - Removing - Stasis - Dispersing Protocol Evaluation of Hench-schonlein Purpura Placebo, "ziying" granules - Purpura, Schoenlein-Henoch | Phase 2 | Unknown | Liaoning University of Traditional Chinese Medicine | 256 | 2009-11-01 | 2010-09-08 |
| Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease Atorvastatin - Kawasaki Disease, Aneurysm, Coronary | Phase 2 | Unknown | National Taiwan University Hospital | 20 | 2007-06-01 | 2014-04-15 |
| Comparison of Two Under Knee Lower Limb Bypass Types:Endothelialised Prosthesis Versus Autologous Vein Graft endothelialised prosthesis - Arteritis | Phase 2 | Unknown | University Hospital, Bordeaux | 40 | 2004-06-01 | 2005-09-22 |
Showing 20 of 22. Sign in to see all of them.
Takayasu Arteritis (3) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Arteritis (2) · Behcet Syndrome (2) · Chronic Limb-Threatening Ischemia (2) · Giant Cell Arteritis (2) · Granulomatosis with Polyangiitis (2) · IgA Vasculitis (2) · Mucocutaneous Lymph Node Syndrome (2) · Peripheral Arterial Disease (2) · Phlebitis (2) · Thromboangiitis Obliterans (2) · Acute Coronary Syndrome (1) · Arteriosclerosis Obliterans (1)
Cardiovascular Diseases (22) · Vascular Diseases (22) · Skin Diseases (16) · Skin and Connective Tissue Diseases (16) · Skin Diseases, Vascular (15) · Immune System Diseases (9) · Arteritis (6) · Autoimmune Diseases (6) · Hemic and Lymphatic Diseases (6) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Peripheral Vascular Diseases (4) · Aortic Arch Syndromes (3) · Aortic Diseases (3)
Cyclophosphamide (2) · Infliximab (2) · Methotrexate (2) · Prednisone (2) · Sodium Chloride (2) · belimumab (2) · tocilizumab (2) · Atorvastatin (1) · COVID-19 Vaccines (1) · CT-P13 (1) · Clobetasol (1) · Dexamethasone (1) · GSK1070806 (1) · Hemoperfusion (1) · Lipectomy (1)
Assistance Publique - Hôpitaux de Paris (2) · Cambridge University Hospitals NHS Foundation Trust (1) · Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation (1) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (1) · Chinese Academy of Medical Sciences, Fuwai Hospital (1) · Komar University of Science and Technology (1) · Liaoning University of Traditional Chinese Medicine (1) · Mashhad University of Medical Sciences (1) · Nanjing Children's Hospital (1) · National Taiwan University Hospital (1) · New York Medical College (1) · Paul R Fortin (1) · Professor Lorraine Harper (1) · Rachel Jones (1) · Royal Brisbane and Women's Hospital (1)
China (3) · France (3) · United Kingdom (3) · United States (2) · Australia (1) · Canada (1) · Germany (1) · Iran (1) · Italy (1) · Russia (1) · South Korea (1) · Taiwan (1)
Aihua Zhang, M.D. (1) · Andew J Sulich, MD (1) · Andrey A Kalinin, MD, PhD (1) · Andrey A Pulin, MD, PhD (1) · Carlo Buzio, MD (1) · Emmanuel Heron, MD (1) · Evgeny R Lysenko, MD, PhD, Prof (1) · Jacques Demotes-Mainard, MD-PhD (1) · Laurence Bordenave, MD-PhD (1) · Lorraine Harper, MRCP PhD (1) · Ming-Tai Lin, MD (1) · Mitchell S. Cairo, MD (1) · Paul R Fortin, MD,MPH,FRCPC (1) · Rachel B Jones (1) · Rona M Smith, MD MRCP (1)
PMID 26312852, PMID 27450392, PMID 29016646, PMID 30102389, PMID 30229280, PMID 33164993, PMID 36853224, PMID 36906660, PMID 38225579
2019 (1)